Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Key takeaways Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist used for blood sugar control in Type 2 diabetes and off-label for weight loss
Who Should Not Use GLP-1 Medications According to standard clinical guidelines and prescribing information, GLP-1 medications may not be appropriate for individuals who: Have a personal or family history of medullary thyroid carcinoma Have multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) Are pregnant, planning to become pregnant, or breastfeeding Have a history of severe allergic reactions to semaglutide, tirzepatide, or any inactive ingredients This is not a replacement for prescribed medical treatment for any health condition
Licensed Mounjaro concentration and per-dose delivery reference
Atkin, Postgraduate Medical Institute & Hull York Medical School, University of Hull, United Kingdom Received: August 17, 2013
US$ 23.43
US$ 23.02
US$ 23.22
